RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TOSI P
Collezione ASL Biella

Items : 5

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma

2024
ASL Biella
AOU Alessandria

Versari A; Luminari S; Pennese E; Perrone T; Liberati AM; Stefani PM; Ibatici A; Usai SV; Falcinelli F; Vitolo U; Gini G; Roti G; Galimberti S; Musto P; Mannina D; Conconi A; Bari A; Massaia M; Califano C; Chiarenza A; Arcari A; Pavone V; Bianchi B; Bolis SAM; Musuraca G; Tosi P; Barbieri E; Ladetto M; Monaco L; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
ASL Città di Torino
ASL Torino 4
AO Cuneo
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
AOU Alessandria

Santini V; Della Porta MG; Giordano L; Finelli C; Pasini P; Naldi I; Turrini M; Tanasi I; Tosi P; Selleri C; Frigeni M; Sancetta R; Norata M; Grimaldi D; Marchetti M; Galimberti S; Fianchi L; Ferrara F; Bono R; Calvisi A; Castelli A; Di Bona E; Di Veroli A; Nicolino B; Occhini U; Rivoli G; Molteni A; Genua A; Guarini A; et alii...

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AOU Alessandria

Merli F; Cattaneo C; Bonuomo V; Busca A; Ferreri AJM; Bruna R; Petrucci L; Cairoli R; Bertù L; Passamonti F; Corradini P; Krampera M; Lanza F; Candoni A; Conconi A; Tosi P; Selleri C; Venditti A; Corso A; Armiento D; Rigacci L; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Cardinali V; Cilloni D; Galimberti S; Bocchia M; et alii...

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS) in Blood

2022
ASL Biella
ASL Torino 4

Lanino L; Salutari P; Perego A; Fattizzo B; Riva M; Ubezio M; Musto P; Cilloni D; Oliva EN; Voso MT; Pelizzari AM; Poloni A; Capodanno I; Elena C; Fozza C; Pane F; Breccia M; De Gobbi M; Di Bassiano F; Barraco D; Crisà E; Ferrero D; Frairia C; Vaccarino A; Griguolo D; Paolini S; Quintini M; Sessa M; Turrini M; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
ASL Biella
AOU Città della Salute di Torino
ASL Torino 5
AOU Novara

Franchi M; Grossi PA; Corradini P; Pagano L; Bertù L; Corrao G; Visco C; Rigacci L; Armiento D; Oberti M; Zappasodi P; Pane F; Galieni P; Candoni A; Venditti A; Fava C; Pinto A; Federici AB; Musto P; Marchesi F; Gentile M; Olivieri A; Bocchia M; Ferrandina C; Di Renzo N; Ortu La Barbera E; Selleri C; Russo D; Ciambelli F; et alii...